CD4 and breast carcinoma: In conclusion, this study has shown that compared to healthy women, breast cancer survivors exhibited higher levels of CD4+ central memory T cells, lower levels of CD8+ naïve T cells and higher activation levels of CD4+ and CD8+ effector-memory T cells.